RecruitingNCT07439757

AI-Powered Precision Decision-Making for Pancreatic Diseases

A Multicenter Clinical Study on AI-Powered Precision Decision-Making Management for Pancreatic Diseases Using Contrast-Enhanced CT


Sponsor

Changhai Hospital

Enrollment

2,000 participants

Start Date

Mar 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This multicenter clinical trial evaluates an artificial intelligence (AI) system designed to assist in the diagnosis and management of pancreatic diseases. Using contrast-enhanced CT scans, the study compares the AI's recommendations against the decisions of experienced clinicians to verify the system's accuracy and safety in a real-world setting. Patients are categorized into three management groups: Intervention (surgery/treatment), Intensive Surveillance (close monitoring), or Routine Surveillance (standard follow-up). The primary goal is to determine if the AI system can reliably classify patients, reduce the risk of missing malignant lesions, and prevent unnecessary surgeries, thereby improving clinical decision-making for pancreatic conditions.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring how artificial intelligence (AI) can improve decision-making for patients with suspected pancreatic diseases. It uses AI-assisted analysis of CT scan images to help doctors diagnose conditions of the pancreas more accurately and quickly. **You may be eligible if...** - You are suspected to have a pancreatic disease (such as pancreatitis or a pancreatic tumor) - You are scheduled to have a contrast-enhanced CT scan (a CT scan using dye to improve image quality) - You have signed informed consent to participate **You may NOT be eligible if...** - You have previously had pancreatic surgery - You are allergic to the contrast dye used in CT scans, or have severe kidney or liver problems that prevent contrast use - Your scan images are of poor quality and cannot be reliably interpreted - You are already in another interventional clinical trial - You are pregnant or breastfeeding, have severe psychiatric illness or cognitive impairment, or have significant health problems that could interfere with the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDiagnosis by Artificial Intelligence model

To develop an artificial intelligence-based classification management system for pancreatic diseases, achieving automated and precise classification. Contrast-enhanced CT images from all study subjects will be analyzed by the AI system to generate classification results, categorizing patients into three groups: INTERVENTIOM, INTENSIVE SURVEILLANCE or ROUTINE SURVEILLANCE.


Locations(1)

Changhai Hospital

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07439757


Related Trials